Asian Pacific Journal of Cancer Prevention

  • 제15권14호
  • /
  • Pages.5767-5772
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling

  • Xiong, Hai-Yu (College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics of Education Ministry, Chongqing Medical University) ;
  • Ma, Ting-Ting (College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics of Education Ministry, Chongqing Medical University) ;
  • Wu, Bi-Tao (College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics of Education Ministry, Chongqing Medical University) ;
  • Lin, Yan (College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics of Education Ministry, Chongqing Medical University) ;
  • Tu, Zhi-Guang (College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics of Education Ministry, Chongqing Medical University)
  • 발행 : 2014.07.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background and Aim: B7-H1, a co-inhibitory molecule of the B7 family, is found aberrantly expressed in ovarian cancer cells and infiltrating macrophage/dendritic-like cells, and plays a critical role in immune evasion by ovarian cancer. IL-12, an inducer of Th1 cell development, exerts immunomodulatory effects on ovarian cancer. However, whether IL-12 regulates B7-H1 expression in human ovarian cancer associated-macrophages has not been clarified. Therefore, we investigated the effects of IL-12 on the expression of B7-H1 in ovarian cancer-associated macrophages and possible mechanisms. Methods: PMA induced THP-1-derived macrophages or human monocyte-derived macrophages were treated with recombinant IL-12 (rIL-12) or infected with adenovirus carrying human IL-12 gene (Ad-IL-12-GFP) for 24 h, then cocultured with the SKOV3 ovarian cancer cell line for another 24 h. Macrophages were collected for real-time PCR and Western blot to detect the expression of B7-H1, and activation of the NF-${\kappa}B$ signaling pathway. Moreover, supernatants were collected to assay for IL-12, IFN-${\gamma}$ and IL-10 by ELISA. In addition, monocyte-derived macrophages treated with IFN-${\gamma}$ were cocultured with SKOV3 and determined for the expression of B7-H1. Furthermore, the expression of B7-H1 in monocyte-derived macrophages was also evaluated after blocking NF-${\kappa}B$ signaling. Results: The expression of B7-H1 was significantly upregulated in monocyte-derived macrophages treated with rIL-12 or Ad-IL-12-GFP compared with the control groups (p<0.05), accompanied by a remarkable upregulation of IFN-${\gamma}$ (p<0.05), a marked downregulation of IL-10 (p<0.05) and activation of NF-${\kappa}B$ signaling. However, the upregulation of B7-H1 was inhibited by blocking the NF-${\kappa}B$ signaling pathway (p<0.05). Expression of B7-H1 was also increased (p<0.05) in monocyte-derived macrophages treated with IFN-${\gamma}$ and cocultured with SKOV3. By contrast, the expression of B7-H1 in THP-1-derived macrophages was significantly decreased when treated in the same way as monocyte-derived macrophages (p<0.05), and IL-10 was also significantly decreased but IFN-${\gamma}$ was almost absent. Conclusions: IL-12 upregulates the expression of B7-H1 in monocyte-derived macrophages, which is possible though inducing the secretion of IFN-${\gamma}$ and further activating the NF-${\kappa}B$ signal pathway. However, IL-12 downregulates the expression of B7-H1 in THP-1-derived macrophages, associated with a lack of IFN-${\gamma}$ and inhibition of expression of IL-10.

키워드

참고문헌

  1. Bever Jr CT, Morgan KD, Whitaker JN (1989). Cathepsin D activity in human peripheral blood mononuclear leukocytes. Inflammation, 13, 309-16. https://doi.org/10.1007/BF00914397
  2. Bloch O, Crane CA, Kaur R (2013). Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res, 19, 3165-75. https://doi.org/10.1158/1078-0432.CCR-12-3314
  3. Brown JA, Dorfman DM, Ma FR, et al (2003). Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol, 170, 1257-66. https://doi.org/10.4049/jimmunol.170.3.1257
  4. Cheng F, Kuang WB, Tu ZG, et al (2012). Construction of adenovirus vector containing hIL-12 gene and its effects on the proliferation and TGF-$\beta$ expression of Hep3B cells. Chinese J Immunol, 28, 402-6.
  5. Cheng XD, Zhao Z, Ventura E, et al (2007). The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J Neuroimmunol, 185, 75-86. https://doi.org/10.1016/j.jneuroim.2007.01.012
  6. Chen YW, Zhang JB, Guo GN, et al (2009). Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9. Molecular Immunology, 46, 375-83. https://doi.org/10.1016/j.molimm.2008.10.026
  7. Cheshire JL, Baldwin AS, et al (1997). Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappa B alpha degradation and de novo I kappa B beta degradation. Molecular Cellular Biology, 17, 6746-54.
  8. Curiel TJ, Wei S, Dong HD, et al (2003). Blockade of B7- H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Medicine, 9, 562-7. https://doi.org/10.1038/nm863
  9. Deb A, Haque SJ, Mogensen T, et al (2001). RNA-dependent protein kinase PKR is required for activation of NF-kappaB by IFN- gamma in a STAT1-independent pathway. J Immunol, 166, 6170-80. https://doi.org/10.4049/jimmunol.166.10.6170
  10. Dong HD, Chen L (2003). B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med, 81, 281-7.
  11. Dong HD, Strome SE, Salomao DR, et al (2002). Tumorassociated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nature Medicine, 8, 793-800.
  12. Dong HD, Zhu GF, Tamada K, et al (1999). B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med, 5, 1365-9. https://doi.org/10.1038/70932
  13. Elhag OAO, Hu XJ, Zhang WY, et al (2012). Reconstructed adeno-associated virus with the extracellular domain of murine PD-1 induces antitumor immunity. Asian Pac J Cancer Prev, 13, 4031-6. https://doi.org/10.7314/APJCP.2012.13.8.4031
  14. Eppihimer MJ, Gunn J, Freeman GJ, et al (2002). Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation, 9, 133-45. https://doi.org/10.1080/713774061
  15. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99. https://doi.org/10.1016/j.cell.2010.01.025
  16. Huang G, Wen QJ, Zhao YL, et al (2013). NF-kB plays a key role in inducing CD274 expression in human monocytes after lipopolysaccharide treatment. PLoS ONE, 8, 61602. https://doi.org/10.1371/journal.pone.0061602
  17. Jain D, Kumar S (2012). Snake venom: a potent anticancer agent. Asian Pacific J Cancer Prev, 13, 4855-60. https://doi.org/10.7314/APJCP.2012.13.10.4855
  18. Karakhanova S, Meisel S, Ring S, et al (2010). ERK/p38 MAPkinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur J Immunol, 40, 254-66.
  19. Kobayashi M, Fitz L, Ryan M, et al (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. JEM, 170, 827-45. https://doi.org/10.1084/jem.170.3.827
  20. Kondo A, Yamashita T, Tamura H, et al (2010). Interferon-$\gamma$ and tumor necrosis factor-$\alpha$ induce an immunoinhibitory molecule, B7-H1, via nuclear factor-${\kappa}B$ activation in blasts in myelodysplastic syndromes. Blood, 116, 1124-31. https://doi.org/10.1182/blood-2009-12-255125
  21. Konishi J, Yamazaki K, Azuma M, et al (2004). B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res, 10, 5094-100. https://doi.org/10.1158/1078-0432.CCR-04-0428
  22. Kuang DM, Zhao QY, Peng C, et al (2009). Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. Exp Med, 206, 1327-37. https://doi.org/10.1084/jem.20082173
  23. Lee SJ, Jang BC, Lee SW, et al (2006). Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Letters, 580, 755-62. https://doi.org/10.1016/j.febslet.2005.12.093
  24. Lee SK, Seo SH, Kima BS, et al (2005). IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J Dermatol Sci, 40, 95-103. https://doi.org/10.1016/j.jdermsci.2005.06.008
  25. Luo JL, Kamata H, Karin M (2005). IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest, 115, 2625-32. https://doi.org/10.1172/JCI26322
  26. Mantovani A, Sica A (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol, 22, 231-7. https://doi.org/10.1016/j.coi.2010.01.009
  27. Ohigashi Y, Sho M, Yamada Y, et al (2005). Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res, 11, 2947-53. https://doi.org/10.1158/1078-0432.CCR-04-1469
  28. Puddu P, Fantuzzi L, Borghi P, et al (1997). IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol, 159, 3490-7.
  29. Stern AS, Podlaski FJ, Hulmes JD, et al (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA, 87, 6808-12. https://doi.org/10.1073/pnas.87.17.6808
  30. Strome SE, Dong HD, Tamura H, et al (2003). B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res, 63, 6501-5.
  31. Tjiu JW, Chen JS, Shun CT, et al (2009). Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol, 129, 1016-25. https://doi.org/10.1038/jid.2008.310
  32. Torres MP, Ponnusamy MP, Lakshmanan I, et al (2009). Immunopathogenesis of ovarian cancer. Minerva Medica, 100, 385-400.
  33. Wang J, Xiao L, Luo CH, et al (2014). Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma. Asian Pac J Cancer Prev, 15, 3955-8. https://doi.org/10.7314/APJCP.2014.15.9.3955
  34. Wang YH, Cao YW, Yang XC, et al (2014). Effect of TLR4 and B7-H1 on Immune Escape of Urothelial Bladder Cancer and its Clinical Significance. Asian Pac J Cancer Prev, 15, 1321-6. https://doi.org/10.7314/APJCP.2014.15.3.1321
  35. Whitworth JM, Alvarez RD (2011). Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature. Expert Opin. Biol. Ther, 11, 751-62. https://doi.org/10.1517/14712598.2011.566854
  36. Wintterle S, Schreiner B, Mitsdoerffer M, et al (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res, 63, 7462-7.
  37. Wu K, Kryczek I, Chen LP, et al (2009). Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1 programmed death-1 interactions. Cancer Res, 69, 8067-75. https://doi.org/10.1158/0008-5472.CAN-09-0901
  38. Wu P, Liang DH, Liu YF, et al (2009). [Effects of high-density lipoprotein 1 on the formation of foam cells from human monocyte-derived macrophages]. Zhonghua Xin Xue Guan Bing Za Zhi, 37 156-60.
  39. Wysocka M, Kubin M, Vieira LQ, et al (1995). Interleukin-12 is required for interferon-$\gamma$ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol, 25, 672-6. https://doi.org/10.1002/eji.1830250307
  40. Xiong HY, Ma TT, Wang Q, et al (2014). The effects of ovarian cancer cells co-cultured with macrophages on the expression of B7-H1 and its mechanisms. Chinese J Cell Biol, 35, 1760-4.

피인용 문헌

  1. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72 vol.12, pp.6, 2015, https://doi.org/10.3892/mmr.2015.4432
  2. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-4384-8
  3. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape vol.18, pp.1, 2019, https://doi.org/10.1186/s12943-018-0928-4